Open AccessExamination of the Relationship Between Oncology Drug Labeling Revision Frequency and FDA Product Categorization
Author(s) -
Robert J. Berlin
Publication year - 2009
Publication title -
american journal of public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.284
H-Index - 264
eISSN - 1541-0048
pISSN - 0090-0036
DOI - 10.2105/ajph.2008.141010
Subject(s) - food and drug administration , medicine , product (mathematics) , orphan drug , drug approval , drug , categorization , family medicine , pharmacology , bioinformatics , computer science , geometry , mathematics , artificial intelligence , biology
I examined the relationship between the Food and Drug Administration's (FDA's) use of special regulatory designations and the frequency with which labels of oncology drugs are revised to explore how the FDA's designation of products relates to product development and refinement.